https://www.selleckchem.com/pr....oducts/BafilomycinA1
Such insights present promising candidates to further investigate for new therapeutic strategies in the treatment of TNBCs.The design, synthesis, and characterization of two novel nonfullerene acceptors (M8 and M34) based on ladder-type heteroheptacenes with different heterocycles are reported. Replacing the furan heterocycles with the thiophene heterocycles in the heteroheptacene backbone leads to a hypsochromically shifted absorption band and greatly improved carrier transport for the resulting nonfullerene acceptor (M34) althou
Like
Comment
Share
